Shyam Sundar
About
Shyam Sundar is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology.
According to data from OpenAlex, Shyam Sundar has authored 431 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 375 papers in Public Health, Environmental and Occupational Health, 219 papers in Epidemiology and 91 papers in Parasitology. Recurrent topics in Shyam Sundar's work include Research on Leishmaniasis Studies (366 papers), Trypanosoma species research and implications (202 papers) and Parasites and Host Interactions (80 papers). Shyam Sundar is often cited by papers focused on Research on Leishmaniasis Studies (366 papers), Trypanosoma species research and implications (202 papers) and Parasites and Host Interactions (80 papers). Shyam Sundar collaborates with scholars based in India, United States and Belgium. Shyam Sundar's co-authors include Jaya Chakravarty, Marleen Boelaert, Simon L. Croft, Alan H. Fairlamb, Henry W. Murray, Madhukar Rai, Suman Rijal, Piero Olliaro, Om Prakash Singh and T. K. Jha and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Shyam Sundar
423 papers receiving 22.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shyam Sundar India | 76 | 19.8k | 12.0k | 4.5k | 3.0k | 2.2k | 431 | 23.1k | ||
| Simon L. Croft United Kingdom | 63 | 10.9k 0.6× | 6.6k 0.6× | 1.7k 0.4× | 4.6k 1.5× | 3.5k 1.6× | 210 | 16.2k | ||
| Marleen Boelaert Belgium | 61 | 12.3k 0.6× | 7.6k 0.6× | 3.5k 0.8× | 1.1k 0.4× | 823 0.4× | 329 | 15.7k | ||
| Caryn Bern United States | 58 | 10.0k 0.5× | 8.6k 0.7× | 5.2k 1.2× | 1.2k 0.4× | 1.0k 0.5× | 194 | 18.0k | ||
| Marc Ouellette Canada | 70 | 8.4k 0.4× | 7.1k 0.6× | 1.9k 0.4× | 1.2k 0.4× | 4.6k 2.1× | 235 | 14.5k | ||
| Peter G. Kremsner Germany | 70 | 11.4k 0.6× | 2.8k 0.2× | 4.2k 0.9× | 408 0.1× | 3.0k 1.4× | 629 | 21.0k | ||
| Pradeep Das India | 48 | 4.7k 0.2× | 2.3k 0.2× | 2.9k 0.6× | 390 0.1× | 944 0.4× | 394 | 8.6k | ||
| Steven R. Meshnick United States | 55 | 5.4k 0.3× | 2.0k 0.2× | 1.3k 0.3× | 752 0.2× | 1.6k 0.7× | 188 | 9.5k | ||
| Johan Neyts Belgium | 77 | 3.6k 0.2× | 6.5k 0.5× | 378 0.1× | 3.7k 1.2× | 6.6k 3.0× | 688 | 24.7k | ||
| Arjen M. Dondorp Thailand | 69 | 13.0k 0.7× | 2.1k 0.2× | 2.4k 0.5× | 391 0.1× | 2.1k 1.0× | 429 | 17.6k | ||
| Louis Maes Belgium | 53 | 3.6k 0.2× | 2.6k 0.2× | 833 0.2× | 2.7k 0.9× | 3.7k 1.7× | 360 | 11.3k |
Countries citing papers authored by Shyam Sundar
Since
Specialization
Citations
This map shows the geographic impact of Shyam Sundar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shyam Sundar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shyam Sundar more than expected).
Fields of papers citing papers by Shyam Sundar
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shyam Sundar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shyam Sundar. The network helps show where Shyam Sundar may publish in the future.
Co-authorship network of co-authors of Shyam Sundar
This figure shows the co-authorship network connecting the top 25 collaborators of Shyam Sundar. A scholar is included among the top collaborators of Shyam Sundar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shyam Sundar. Shyam Sundar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Singh, Vishal, Mallikarjuna Rao Gedda, Om Prakash Singh, et al.. (2025). Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment. ACS Omega. 10(25). 26627–26638.
2.
Kumar, Shashi Bhushan, Shashi Bhushan Chauhan, Siddharth Singh, et al.. (2024). Altered IL-7 signaling in CD4+ T cells from patients with visceral leishmaniasis. PLoS neglected tropical diseases. 18(2). e0011960–e0011960.
3.
Mukherjee, Kamalika, Saikat Chakrabarti, Syamal Roy, et al.. (2020). MicroRNA exporter HuR clears the internalized pathogens by promoting pro‐inflammatory response in infected macrophages. EMBO Molecular Medicine. 12(3). e11011–e11011.
4.
Gedda, Mallikarjuna Rao, Alok K. Vishwakarma, Ganesh Yadagiri, et al.. (2020). Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study. Frontiers in Chemistry. 8. 510–510.
5.
Gedda, Mallikarjuna Rao, et al.. (2020). Nanodiagnostics in leishmaniasis: A new frontiers for early elimination. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 13(2). e1675–e1675.
6.
Singh, Bhawana, Siddharth Singh, & Shyam Sundar. (2018). Hepcidin mediated iron homoeostasis as immune regulator in visceral leishmaniasis patients. Parasite Immunology. 41(1). e12601–e12601.
7.
Singh, Neetu & Shyam Sundar. (2018). Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. PLoS ONE. 13(6). e0199817–e0199817.
8.
Singh, Neetu & Shyam Sundar. (2017). Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells. Molecular Immunology. 85. 111–119.
9.
Singh, Neetu, Rajiv Kumar, Christian Engwerda, et al.. (2016). Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients. Cytokine. 85. 184–190.
10.
Pathak, Abhishek, et al.. (2014). A pilot study to evaluate the effect of HAART on gonadal dysfunction in male HIV patients. National Journal of Physiology Pharmacy and Pharmacology. 5(1). 33–33.
11.
Mukherjee, Budhaditya, Rupkatha Mukhopadhyay, Sayan Mullick Chowdhury, et al.. (2013). Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proceedings of the National Academy of Sciences. 110(7). E575–82.
12.
Cunningham, Jane, Epco Hasker, Murari Lal Das, et al.. (2012). A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis. Clinical Infectious Diseases. 55(10). 1312–1319.
13.
Tiwary, Puja, Dinesh Kumar, Rudra Pratap Singh, Madhukar Rai, & Shyam Sundar. (2012). Prevalence of Sand Flies and Leishmania donovani Infection in a Natural Population of Female Phlebotomus argentipes in Bihar State, India. Vector-Borne and Zoonotic Diseases. 12(6). 467–472.
14.
Sundar, Shyam, Prabhat Kumar Sinha, Madhukar Rai, et al.. (2011). Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. The Lancet. 377(9764). 477–486.
15.
Downing, Tim, Olivia Stark, Manu Vanaerschot, et al.. (2011). Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infection Genetics and Evolution. 12(1). 149–159.
16.
Mohapatra, T M, et al.. (2009). Compararative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis. The Journal of Infection in Developing Countries. 4(2). 114–117.
17.
Sundar, Shyam, Neha Agrawal, Rakesh Arora, et al.. (2009). Short‐Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14‐Day vs 21‐Day Treatment. Clinical Infectious Diseases. 49(6). 914–918.
18.
Nylén, Susanne, Radheshyam Maurya, Liv Eidsmo, et al.. (2007). Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. The Journal of Experimental Medicine. 204(4). 805–817.
19.
Sundar, Shyam, T. K. Jha, C.P. Thakur, et al.. (2002). Oral Miltefosine for Indian Visceral Leishmaniasis. New England Journal of Medicine. 347(22). 1739–1746.
20.
Sundar, Shyam, et al.. (1984). Coxsackie--a viral carditis in eastern India.. PubMed. 32(6). 501–3.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Simon L. Croft Breakdown of academic impact, for papers by Marleen Boelaert Breakdown of academic impact, for papers by Caryn Bern Breakdown of academic impact, for papers by Marc Ouellette Breakdown of academic impact, for papers by Peter G. Kremsner Breakdown of academic impact, for papers by Pradeep Das Breakdown of academic impact, for papers by Steven R. Meshnick Breakdown of academic impact, for papers by Johan Neyts Breakdown of academic impact, for papers by Arjen M. Dondorp Breakdown of academic impact, for papers by Louis Maes